Susquehanna International Group’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.67M Sell
13,900
-17,800
-56% -$9.11M ﹤0.01% 3750
2025
Q4
$17.8M Sell
31,700
-86,400
-73% -$49M ﹤0.01% 2335
2025
Q3
$60.7M Buy
118,100
+47,200
+67% +$20.6M 0.01% 1210
2025
Q2
$22.3M Buy
70,900
+34,300
+94% +$10.3M ﹤0.01% 1899
2025
Q1
$11.2M Sell
36,600
-2,100
-5% -$706K ﹤0.01% 2387
2024
Q4
$12.9M Sell
38,700
-47,000
-55% -$15.9M ﹤0.01% 2338
2024
Q3
$28.6M Buy
85,700
+60,000
+233% +$22.8M 0.01% 1497
2024
Q2
$10.6M Buy
25,700
+14,600
+132% +$5.78M ﹤0.01% 2415
2024
Q1
$4.49M Buy
11,100
+2,800
+34% +$984K ﹤0.01% 3796
2023
Q4
$2.54M Buy
8,300
+1,800
+28% +$486K ﹤0.01% 4868
2023
Q3
$1.57M Sell
6,500
-14,700
-69% -$3.76M ﹤0.01% 5625
2023
Q2
$5.09M Buy
21,200
+12,500
+144% +$2.6M ﹤0.01% 3501
2023
Q1
$1.64M Sell
8,700
-6,100
-41% -$1.26M ﹤0.01% 5585
2022
Q4
$3.14M Sell
14,800
-14,500
-49% -$2.9M ﹤0.01% 3940
2022
Q3
$4.61M Buy
29,300
+1,800
+7% +$287K ﹤0.01% 3295
2022
Q2
$4.12M Sell
27,500
-1,700
-6% -$246K ﹤0.01% 3503
2022
Q1
$4.78M Buy
+29,200
New +$4.81M ﹤0.01% 3709
2021
Q4
Sell
-11,800
Closed -$2.23M 13582
2021
Q3
$2.23M Buy
11,800
+4,300
+57% +$784K ﹤0.01% 5589
2021
Q2
$1.32M Buy
7,500
+5,200
+226% +$897K ﹤0.01% 6977
2021
Q1
$377K Sell
2,300
-14,900
-87% -$2.28M ﹤0.01% 10116
2020
Q4
$2.39M Buy
17,200
+10,400
+153% +$1.31M ﹤0.01% 4723
2020
Q3
$760K Sell
6,800
-8,900
-57% -$1.03M ﹤0.01% 6785
2020
Q2
$1.46M Sell
15,700
-800
-5% -$68.1K ﹤0.01% 5087
2020
Q1
$1.21M Sell
16,500
-22,500
-58% -$1.95M ﹤0.01% 4948
2019
Q4
$3.28M Hold
39,000
﹤0.01% 3557
2019
Q3
$3.28M Sell
39,000
-2,100
-5% -$159K ﹤0.01% 3352
2019
Q2
$2.69M Sell
41,100
-48,900
-54% -$2.82M ﹤0.01% 3638
2019
Q1
$5.31M Buy
90,000
+66,100
+277% +$3.95M ﹤0.01% 2373
2018
Q4
$1.26M Sell
23,900
-9,300
-28% -$511K ﹤0.01% 4260
2018
Q3
$1.99M Buy
+33,200
New +$1.82M ﹤0.01% 4009

Other funds holding MEDP

Susquehanna International Group's MEDP Position: Q1 2026 in Review

Susquehanna International Group reduced its Medpace (MEDP) stake by 77% in Q1 2026, selling an estimated $1.72M and leaving 978 shares worth $470K. The position accounts for ﹤0.01% of the portfolio, ranked #9837.

Susquehanna International Group first reported a position in MEDP in Q2 2017 and has held it in 31 quarters since. The position peaked at $35.1M in Q2 2023. 731 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Susquehanna International Group held 978 shares of Medpace worth $470K as of Q1 2026.
  • Susquehanna International Group sold 3,354 Medpace shares in Q1 2026, an estimated $1.72M.
  • Medpace made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #9837 holding.
  • Susquehanna International Group first reported a position in Medpace in Q2 2017 and has held it in 31 quarters since.
  • Susquehanna International Group's Medpace position peaked at $35.1M in Q2 2023.
  • 731 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.